Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
-658K
-
Total reported value, excl. options
-
$176M
-
Value change
-
-$8.28M
-
Number of buys
-
43
-
Number of sells
-
-19
-
Price
-
$11.70
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2017
73 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q3 2017.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 86.6M outstanding shares and own 17.37% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.1M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), BlackRock Inc. (1.95M shares), FMR LLC (1.1M shares), JENNISON ASSOCIATES LLC (952K shares), VANGUARD GROUP INC (604K shares), ArrowMark Colorado Holdings LLC (498K shares), ORBIMED ADVISORS LLC (437K shares), MILLENNIUM MANAGEMENT LLC (434K shares), and JPMORGAN CHASE & CO (420K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.